One of the notable novel approvals in the first quarter of 2025 is suzetrigine (Journavx)
Your healthcare provider will conduct a thorough assessment, which may include: Physical examination to assess the extent and nature of swelling Review of all current medications to identify potential causes Blood tests to evaluate kidney function, liver function, and electrolyte balance Urine tests to check for protein or other abnormalities Cardiac assessment if heart failure is suspected Keep a symptom diary noting when swelling occurs, its severity, any associated symptoms, and potential triggers
Abstract GLP-1 analogs have been widely used to treat patients with type 2 diabetes in recent years and studies have found that GLP-1 analogs have multiple organ benefits
Gorman MJ, Patel N, Guebre-Xabier M, Zhu AL, Atyeo C, Pullen KM, et al
Neither scenario typically requires a dose adjustment, but your clinician can confirm what works best for your specific situation
Reaction 2: 6-Phosphogluconolactone + HO 6-Phosphogluconate The hydrolysis of 6-phosphogluconolactone to create 6-phosphogluconate is the first step in the non-oxidative phase